8-K ·Filed Jul 22, 2026

SCLX

Scilex Holding Co
MIXED
Impact 5/10
Horizonweeks Processed2mo ago SEC0001193125-26-312591
Actionable Insight ◆ Mixed

Monitor receipt of the first $1M tranche and subsequent payments. The related-party nature and the company's broader capital needs (iHolding investment, Bitcoin purchase) suggest ongoing distress. Watch for any default on tranche payments or further dilutive financing.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d
SCLX ▼ -21.52% at T+20d
NEUTRAL call ✗ call lost -21.52% · α vs SPY -24.82% · entry $7.39 → $5.80
Next anchor: T+60d in 12d
Latest observation: T+49 -90.18% FF3 residual α
Entry anchored
Jul 22, 03:51 PM ET
via exchange tick
T+1d
-7.44%
call -7.44% · α -7.54%
$6.84
settled 2mo ago
T+5d
-10.69%
call -10.69% · α -11.17%
$6.60
settled 2mo ago
T+20d
-21.52%
call -21.52% · α -24.82%
$5.80
settled 6w ago
T+60d
—
call — · α —
—
in 12d

Price Chart

Loading chart...

Executive Summary

Scilex Holding Co. completed the sale of its Vivasor preferred shares back to Vivasor for ~$12M, payable in five tranches through June 2027. The transaction provides near-term liquidity for a cash-strapped company but is a related-party deal (CEO Henry Ji leads both entities) and the proceeds are modest relative to Scilex's $67M market cap and going-concern risks. Combined with the pending $100M iHolding investment and the Bitcoin purchase agreement, this filing underscores ongoing financial distress and multiple capital-raising efforts.

Key Financial Metrics

Deal Value
$12.0M
Deal Type
other

Key Facts

  • Scilex sold 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares for $11,999,762.28 ($1.8583/share).
  • Payment is in five tranches: $999,980.97 on July 18, 2026; $4,999,901.10 by Sep 30, 2026; $1,999,960.07 by Dec 31, 2026; $1,999,960.07 by Mar 31, 2027; $1,999,960.07 by Jun 30, 2027.
  • Payment may be in cash or assignment of Datavault AI (DVLT) shares held by Vivasor's subsidiary.
  • Dr. Henry Ji, Scilex's CEO, is also CEO of Vivasor — a related-party transaction.
  • The shares were originally acquired by Scilex in January 2026.
  • Scilex has a going-concern audit opinion and a prior shelf registration, per cross-filing context.

Financial Impact

~$12M in cash or DVLT stock receivable over ~12 months, representing ~18% of Scilex's $67M market cap.

cashliquidityrelated-party exposure

Risk Factors

  • Related-party transaction risk — terms may not be at arm's length.
  • Tranche payment default risk — Vivasor may fail to make future payments.
  • Ongoing going-concern risk — Scilex's liquidity remains precarious despite this inflow.
  • Dilution risk from the pending Bitcoin purchase and iHolding investment.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (SCLX) — Batch item 10001193125-26-312591
Document: sclx-20260718.htm0001193125-26-312591
Document: 0001193125-26-312591-index-headers.html0001193125-26-312591
Document: 0001193125-26-312591-index.html0001193125-26-312591
Document: 0001193125-26-312591.txt0001193125-26-312591
8-K Filing (SCLX) — Batch item 60001193125-26-312591
Document: sclx-20260718.htm0001193125-26-312591
Document: 0001193125-26-312591-index-headers.html0001193125-26-312591
Document: 0001193125-26-312591-index.html0001193125-26-312591
Document: 0001193125-26-312591.txt0001193125-26-312591
11 reports for SCLX
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +36.82%Jun 12, 2026
Filters
Rows
Reports for SCLX — sortable, filterable
TypeNow
Jul 22, 2026
10w ago
8-K
MIXED ★ 5/10
$7.39 $5.80▼ −21.52%▼ −24.82%$4.06 (−45.06%)
Jul 6, 2026
12w ago
8-K
MIXED ★ 6/10
$8.07 $6.67▼ −17.41%▼ −16.84%$4.06 (−49.69%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$7.80 $7.03▲ +9.87%▲ +8.84%$4.06 (+47.95%)
Jun 12, 2026
16w ago
Press Release
NEUTRAL ★ 2/10
$8.50 $9.48▲ +11.53%▲ +9.75%$4.06 (−52.24%)
Jun 12, 2026
16w ago
EFFECT
BEARISH ★ 6/10
$8.50 $9.48▼ −11.53%▼ −9.75%$4.06 (+52.24%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 2/10
$8.70 $9.20▲ +5.75%▲ +3.86%$4.06 (−53.33%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$4.72 $7.81▲ +65.47%▲ +66.85%$4.06 (−13.98%)
May 5, 2026
21w ago
Press Release
BULLISH ★ 8/10
$6.68 $4.46▼ −33.18%▼ −37.39%$4.06 (−39.23%)
May 4, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$6.94 $4.61▼ −33.63%▼ −39.42%$4.06 (−41.52%)
Apr 17, 2026
24w ago
Insider Cluster
MIXED ★ 6/10
$4.30 $3.92▼ −8.84%▼ −12.93%$4.06 (−5.50%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (56h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access